James Smith
Roger Sanchez
James Smith- pharma
- November 11, 2026
- 11 views
Sushi-monjaro imports: Are They the Best Solution for Drug Prices?
Sushi-monjaro imports could impact obesity drug prices in Korea. Discover the implications today.
- James Smith
- pharma
- November 7, 2026
- 13 views
Cancer Drug Price Cuts: Smart Move to Save Rs 3,502 Crore
Cancer drug price cuts are set to save Rs 3,502 crore annually, benefiting patients and healthcare.
- James Smith
- Pharma News
- November 4, 2026
- 16 views
Amber Enterprises acquisition: Proven strategy for growth
Amber Enterprises acquisition is a significant move in the pharma sector, enhancing market presence and capabilities.
- James Smith
- Pharmaceuticals
- October 31, 2026
- 17 views
India Medicine Pricing: The Real Gaps Exposed by Drug Cuts
India medicine pricing reveals significant gaps in affordability and access.
- James Smith
- pharma
- October 29, 2026
- 29 views
Anti Cancer Drugs: The Real Impact of Price Cuts Revealed
Anti cancer drugs are under scrutiny as public health campaigners question the Centre’s recent price cuts.
- James Smith
- pharma
- October 26, 2026
- 26 views
Stroke-prevention drug: Safe New Class with Proven Benefits
Stroke-prevention drug approval in China marks a global first for Bayer, offering new hope in treatment.
- James Smith
- pharma
- October 21, 2026
- 31 views
Hepatitis B Approval: Proven Cure Strategy Gains Focus
Hepatitis B Approval highlights GSK’s innovative approach to treatment.
- James Smith
- pharma
- October 18, 2026
- 30 views
Anuh Pharma Tarapur Plant: Proven Boost for API Capacity
Anuh Pharma Tarapur Plant acquisition boosts API capacity significantly. Discover the details behind this strategic move.
- James Smith
- Law
- October 17, 2026
- 39 views
How to Choose the Right Patent Lawyer for Your Intellectual Property Goals
Learn how to choose the right patent lawyer for your intellectual property goals with essential tips and considerations.
- James Smith
- pharma
- October 14, 2026
- 34 views
FDA Approval Pill: Worth a Proven $400M+ Opportunity
FDA approval pill could revolutionize treatment and is projected to generate over $400 million in revenue.